Claritas HealthTech Further Expands Global Presence with Entry into Brazil Focusing on its Solutions in Nuclear Medicine
May 13 2024 - 2:40PM
Claritas HealthTech (“Claritas”), a healthcare
technology company specializing in advanced medical image
enhancement, reconstruction, and AI solutions for the
medical industry, is pleased to announce today, that it has
selected Sao Paulo as its base for its Brazilian business
headquarters.
With an established presence in Asia and a
successful entry into the European and North American markets, the
new Sao Paulo base will cater to meet Brazil’s existing and rapidly
growing demand for imaging solutions in nuclear medicine. Mr.
Chetan Baxi, Co-founder and Director of Claritas, commented, “After
completing the initial tests and validations with our Brazilian
partners, we are confident that iPET™, our nuclear medicine
platform will provide rapid, accurate and affordable imaging
solutions to benefit patients, clinicians, and hospitals.”
Claritas in Brazil will be led by Dr Fernando
Salis, a twenty-year veteran in the nuclear medicine industry. Dr
Salis commented, “Having reviewed the various available imaging
solutions in the nuclear medicine field, I can say with confidence
that Claritas iPET™ is by far the most advanced and accurate
solutions in the market. iPET™ has the potential to transform the
nuclear medicine imaging market providing significant benefits to
patients with reduced radiation exposure, and for clinicians with
accurate readings.”
As part of this initiative, Claritas aims to
establish collaborations with leading stakeholders in Brazil for
effective rollout and deployment. The company aims to commence
several R&D collaborations with leading medical institutions in
Brazil by Q4 this year.
About Claritas
HealthTech
Claritas conducts research and development in
the fields of image enhancement, machine vision and artificial
intelligence (“AI”) with a focus on medical image processing and
AI-assisted interpretation and diagnostics. Claritas aims to
transform the diagnostics industry with powerful and effective
software products created using image enhancement and AI
technology, enabling and assisting doctors and physicians to make
accurate diagnosis and improve patient lives. All Claritas
products, including iRAD and iPET, are fully compliant with HIPPA
and GDPR requirements.
For more information, please visit
www.claritashealthtech.com
For Media Enquiries, please contact:
Devika Dutt
Claritas HealthTech Ltd
d.d@claritasco.com